ArticlePDF Available

RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE END EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors:

Figures

Content may be subject to copyright.
Int J Physiother Res 2017;5(5):2344-48. ISSN 2321-1822 2344
Original Research Article
RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE END
EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY
DISEASE
Mohamed Sh. Mosa *
1
, Azza A. El Aziz
2
, Amany R. Mohamed
3
, Marwa M. Shaban
4
.
*1 MSc Physical Therapy Student, Faculty of Physical Therapy, Cairo University, Egypt.
2 Professor of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics, Faculty of
Physical Therapy, Cairo University, Egypt.
3 Consultant (Professor) of Physical Therapy, Critical Care Department, Cairo University Hospitals,
Egypt.
4 Assistant Professor of Chest Diseases, Faculty of Medicine, Cairo University, Egypt.
Introduction: Although expiratory muscles have been little studied it is known that expiratory muscle strength is
impaired in most patients with significant chronic obstructive pulmonary disease (COPD), the expiratory muscles
partake in the generalized muscle weakness that is observed in those patients. The decreased expiratory muscle
strength was associated with reduced patient’s exercise capacity. There is need to find an alternate cost effective,
easy technique which can help strength the expiratory muscles and improve the exercise capacity. An interven-
tion like applying positive end expiratory pressure (PEEP) training could help in strengthening of expiratory
muscles and improving the exercise capacity in patient with COPD.
Procedure: Forty COPD male patients were assigned into two equal groups: Group A consisted of 20 males whom
received PEEP (10-20 cm H2o, 15 minutes session, once daily for 4 weeks) plus standard chest physiotherapy.
Group B consisted of 20 males received standard chest physiotherapy only. Maximum Expiratory pressure (MEP)
and Six-minute walk distance (6MWD) were measured for each patient before and after treatment.
Results: There was a significant difference (p= 0.041) between study and control group patients in MEP post
treatment (84.35 ± 9.73 vs 77 ± 12.11 cm H2o). There was significant difference (p= 0.045) between study and
control group patients in 6MWT post treatment (339.7 ± 54.126 vs 301.65 ± 61.78).
Conclusion: Positive expiratory pressure therapy is efficient in improving the expiratory muscle strength and
exercises capacity and helps COPD patients to improve their active life.
KEY WORD: COPD, PEEP, Expiratory muscles, MEP, 6MWT.
ABSTRACT
INTRODUCTION
Address for correspondence: Mr. Mohamed Sh. Mosa, MSc Physical Therapy Student, Faculty of
Physical Therapy, Cairo University, Egypt. E-Mail: mohamed.s.mosa@gmail.com
International Journal of Physiotherapy and Research,
Int J Physiother Res 2017, Vol 5(5):2344-48. ISSN 2321-1822
DOI: https://dx.doi.org/10.16965/ijpr.2017.207
Quick Response code
Access this Article online
International Journal of Physiotherapy and Research
ISSN 2321- 1822
www.ijmhr.org/ijpr.html
DOI: 10.16965/ijpr.2017.207
Received: 31-07-2017
Peer Review: 31-07-2017
Revised: None
Accepted: 16-08-2017
Published (O): 11-09-2017
Published (P): 11-10-2017
the focus of intense research because of its
persistently increasing prevalence, mortality [1].
COPD is a preventable and treatable disease
that characterized by Reduction in oxygenation,
pulmonary functions, and respiratory muscle
strength, as well as radiological changes such
(COPD) is a syndrome characterized and defined
by a single physiological parameter: limitation
of expiratory airflow. COPD has gained interest
as a major public health concern and is currently
Int J Physiother Res 2017;5(5):2344-48. ISSN 2321-1822 2345
as atelectasis and air flow limitation which is
not fully reversible. associated with an abnor-
mal inflammatory response of the lung to
cigarette smoke and other noxious particles or
gases [1].
It is more likely that expiratory muscles of COPD
patients, which persistently work under the
overloads of increased airway resistance and
decreased lung elastic recoil, would develop
muscle dysfunction. It should be recognized,
however, that the intensity of expiratory muscle
dysfunction appears to be relatively low if
compared with weakness shown by COPD
patients in peripheral or inspiratory muscles [2].
(PEEP) therapy involves the application of a
resistance to expiration in order to produce
positive airway pressure. It is thought to stabi-
lize airways, prevent premature airway closure
improve ventilation and reduce gas trapping.
It has been used, and is recommended, as
component of respiratory physiotherapy man-
agement for varying groups including those with
cystic fibrosis acute and chronic respiratory dis-
ease and in the post-operative setting. Improve-
ments in secretion clearance, functional residual
capacity and oxygenation have been demon-
strated with the use of positive expiratory pres-
sure therapy [3].
However, there is little information about the
actual clinical usage of( the technique, there is
little definition of the patient groups most com-
monly prescribed PEEP therapy, the methods of
administration [3].
Since muscle weakness might be improved
through different mechanisms by training. These
problems arouse our interest to investigate the
response of expiratory muscle training to PEEP
on COPD patients.
This study was designed to respond to the rela-
tive lack of information about the impact of us-
ing PEEP therapy on expiratory muscle strength
measured by maximum expiratory pressure MEP
and exercise capacity measured by six-minute
walking test (6MWT).
differences (p >0.05) between both groups in
age. They were selected from the chest depart-
ment , faculty of Medicine, Kasr Al Einy hospi-
tal.
Inclusion criteria: All Patients included in this
study were diagnosed as mild to severe COPD,on
optimized medical therapy all over the study,
clinically stable (not suffering from recent res-
piratory tract infection 3 weeks before the study),
they are willing to participate in the study.
Materials Used: 1. peep device (Astra Tech AB,
Export, Sweden). 2. Micro Respiratory Pressure
Meter (Micro RPM) from Micro Medical Ltd. 3.
Stopwatch 4.an expiratory airway pressure indi-
cator. 5. Pen and paper.
Forty COPD male patients were assigned into
two equal groups: Group A consisted of 20 males
with received (PEEP) (10-20 cm H2o, 15 minutes
session, 1times per day-daily for 4 weeks) plus
standard chest physiotherapy (postural drainage,
percussion, vibration, and breathing exercises).
Group B consisted of 20 males received stan-
dard chest physiotherapy only. Maximum Expi-
ratory pressure (MEP) and Six-minute walk dis-
tance (6MWD) was measured for each patient
before and after treatment
Procedures: A verbal explanation about the
importance of this study procedure, main aims
and conceptual approach was explained to ev-
ery patient. an informed written consent was
taken from them.
The procedures of this study divided into two
main procedures: subjects in group A use (PEEP)
device with one session daily for 4 consecutive
weeks the patients had to breath in, but not to
total lung capacity then exhale gently, the pres-
sure detected by an expiratory airway pressure
indicator is inserted into the system to pressure
range from 10–20 cm H2O. Exhalation time
lasted approximately 3 times longer than inha-
lation. One minute of PEEP breathing was fol-
lowed by 2-3 forced expirations or huffs, a short
period of relaxation and controlled breathing.
Then repeat for 15 minutes (should stop if they
experience breathlessness or any severe dis-
comfort).
In both groups MEP (cm H2o) to measure the
expiratory muscles strength and 6MWT (meter)
to measure the exercise capacity was taken pre
MATERIALS AND METHODS
Subjects:
Forty COPD male patients, their ages ranged
from 45 to 65 years. There were no significance
Mohamed Sh. Mosa, Azza A. El Aziz, Amany R. Mohamed, Marwa M. Shaban. RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE
END EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Int J Physiother Res 2017;5(5):2344-48. ISSN 2321-1822 2346
and post the study for each patient [4,5,6].
Statistical procedures: Statistics were analyzed
using SPSS software package. Results are shown
as the mean ± SD. Both t-tests were used to
assess significance of differences within each
group and between the two groups. Significance
was accepted as P-value < 0.05.
In study group the mean values ± SD of maxi-
mum expiratory pressure increased from 70.3±
8.7 to 84.35 ± 9.76 cm H2o after applying Posi-
tive End Expiratory Pressure (PEEP). The mean
difference was -14.05. Which is highly signifi-
cance (P=0.000).
In control group the mean values ± SD of maxi-
mum expiratory pressure before the experiment
was 76.6 ± 13.22 cm H2o while after the experi-
ment was 77 ± 12.118 cm H2o. The mean differ-
ence was - 0.4. which is statistically insignifi-
cant (P=0.438).
RESULTS
Table 1: MEP before and after treatment for the study
group.
Table 2: MEP before and after treatment for the control
group.
Table 3: 6MWT before and after treatment for the study
group.
was -48.35. Which is highly significant (P=0.000).
In control group the mean values ± SD of 6
minutes’ walk test before the experiment was
298.95 ± 62.27 while after the experiment was
301.65 ± 61.27. The mean difference was -21.2
Which is statistically insignificant (P=0.142).
Table 4: 6MWT before and after treatment for the control
group.
In study group the mean values ± SD of 6
minutes’ walk test increased from 291.35 ±58.86
to 339.7 ± 54.126 after applying Positive End
Expiratory Pressure (PEEP). The mean difference
DISCUSSION
There is much less data related to the expira-
tory muscles in COPD patients, However the
expiratory muscle strength is impaired in most
patients with significant COPD., the expiratory
muscles partake in the generalized muscle weak-
ness that is observed in patients with COPD. The
decreased expiratory muscle strength was
associated with reduced exercise capacity and
reduced quality of life [7].
This study was designed to respond to the
relative lack of information about the impact of
using peep on expiratory muscle strength
measured by MEP and submaximal exercise
capacity measured by (6MWT).
The result of our study revealed statistically
significant improvement in expiratory muscle
strength (MEP), and exercise capacity (6MWT)
after using the PEEP. as expiratory muscles can
be trained similarly to the peripheral muscles
with inexpensive devices that increase the
resistive or threshold expiratory load on the
expiratory muscles.
While decreased expiratory muscle strength was
associated with reduced patient’s exercise
capacity [8] then wherever the expiratory muscle
become stronger the patient significantly
improved in their exercise capacity measures as
the result of our study. And consequently,
suggest a causative role for the former mechan-
ism(PEEP).
Our findings are consistent with the results of
the Study done by Nicolini A et al., 2014, Re-
sults supporting the use and the effectiveness
of PEEP in (COPD) patients.
The difference that the study was three groups
of intermittent positive pressure breathing(IPPB)
temporary positive expiratory pressure(TPEP)
and a group with pharmacological therapy alone,
mean age was relatively higher 70±6, The dura-
tion of each treatment was 30 min per session
Mohamed Sh. Mosa, Azza A. El Aziz, Amany R. Mohamed, Marwa M. Shaban. RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE
END EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
±SD Min max
Before 70.3 ± 8.7 54 90
After 84.35 ± 9.76 65 105
Item MEP (cm H2o) MD t-value P-value Sig
-14.1 -8.736 0.000 S
±SD Min max
Before 76.6 ± 13.22 57 105
After 77 ± 12.118 57 100
MEP (cm H2o)
Item MD t -value P-value Sig
-0.4 -0.793 0.438 NS
±SD Min max
Before 291.35 ± 58.86 163 395
After 339.7 ± 54.126 215 439
Item 6MWT (me ter) MD t-value P-value Sig
-48.4 -13.79 0.000 S
±SD Min max
Before 298.95 ± 62.27 190 390
After 3 01.65 ± 61.78 197 403
6MWT (meter)
Item MD t-value P-value Sig
-2.7 -1.532 0.142 NS
Int J Physiother Res 2017;5(5):2344-48. ISSN 2321-1822 2347
and was given twice daily with pressure only1cm
H2O [9].
Our findings are also consistent with the results
of the study in 2013, Nicolini et al., they used
the positive expiratory pressure (PEP) during the
6MWT which found that low threshold PEP of
only 5cmH2O improved the distance walked in
patients with moderate-to-severe COPD [10].
However, Wibmer et al., 2014 investigated the
same kind of patients and found that, with a
flow-dependent PEP in the range of 10–20 cm
H2O, patients walked 30.8m less than the con-
trols without devices [11].
Furthermore, Study by Mascardi V et al.,2016
using Temporary positive expiratory pressure
(T-PEP) a device which applies an expiratory
pressure d”1 cmH2O only two-week treatment
with T-PEP but in this study in hospital and at
home, Result revealed that MEP and 6MWT im-
proved significantly in the two TPEP groups [12].
Also, Study done by Chien-Ling Su et al., 2006
stated that Four-week of positive expiratory pres-
sure (PEP) as an adjunct to forced expiratory
technique (FET) further enhanced 6minute walk
distance(6MWD), and reduced cough difficulty
compared to FET only in COPD patients with
mucus hypersecretion [13].
However, Study done by Russo D et al., 2016 in
patients with severe COPD, the application of
1cmH2O of PEP seems to improve the exercise
tolerance as 10 cmH2O, with similar dyspnea
during 6MWT [14].
Martin et al.,2011 applied two levels of thresh-
old PEP (13.8 and 2 cm H2O) and demonstrated
a significant decrease in dyspnea with the use
of the higher level of PEP after a treadmill
constant load test. the authors applied PEP only
after the conclusion of the exercise test, rather
than before - as our study- or during effort [15].
Weiner et al.,2003 studied the effects of expi-
ratory muscle strength training (EMST) on expi-
ratory muscle strength and, exercise perfor-
mance as the participants of both groups ex-
haled through the expiratory port of the (Thresh-
old Inspiratory Muscle Trainer). The treatment
group, the expiratory load modified from 15 to
60 percent of their MEP, and the sham group
was trained with a low load of 7 cm H2O they
reported statistically significant changes in the
treatment group: an increase (21%) in the MEP
and statistically significant increase (19%) in the
distance walked during 6MWT [7].
Finally, Future studies may lead to a more prac-
tical utilization of positive expiratory therapy.
And further studies needed to test the effects
of different levels PEEP on expiratory muscle
strength and during aerobic and strength train-
ing protocol.
ACKNOWLEDGEMENTS
The authors acknowledge the Cardiovascular/
Respiratory Disorder and Geriatrics department,
Faculty of physical therapy, Cairo University and
Chest Diseases department, Faculty of Medi-
cine, Cairo University for providing resources
that contributed to this study.
Conflicts of interest: None
REFERENCES
[1]. Spyratos D, Chloros D, Sichletidis L (Diagnosis of
chronic obstructive pulmonary disease in the pri-
mary care setting. Hippokratia 2012;16(1):17-22.
[2]. Susana Mota, Rosa Gu ell, Esther Barreiro, Ingrid
Solanes, Alba Ram ýrez-Sarmiento, Mauricio Orozco-
Levi, Pere Casan, Joaquim Gea, Joaquin Sanchis,
Clinical outcomes of expiratory muscle training in
seve re COPD patients, respirat ory Medicine
2007;101;516–524.
[3]. Johnston CL, James R, Mackney JH.The current use of
positive expiratory pressure (PEP) therapy by pub-
lic hospital physiotherapists in New South Wales.
New Zealand Journal of Physiotherapy 2013;4
1(3):88-93.
[4]. American Thoracic Society Statement. Guidelines
for the six-minute walk test. Am J Respir Crit Care
Med 2002;166:111–7.
[5]. Acquistapace F, Piepoli M: The walking test: use in
clinical practice. Monaldi Arch Chest Dis 2009;72:3–
9.
[6]. Enright, P. L., Kronmal, R. A., Manolio, T. A., Schenker,
M. B. & Hyatt, R. E. Respiratory muscle strength in
the elderly. Correlates and reference values. Car-
diovascular Health Study Research Group. Ameri-
can Journal of Respiratory and Critical Care Medi-
cine, 1994;149(2):430-438.(
[7]. Weiner P, Magadle R, Beckerman M, Weiner M, Berar-
Yanay N. Specific expiratory muscle training in COPD.
Chest. 2003;124(2):468–73.
[8]. Ramirez-Sarmiento A, Orozco-Levi M, Barriero E, et
al. Expiratory muscle endurance in chronic obstruc-
tive pulmonary disease. Thorax 2002;57:132–136.
[9]. Nicolini A, Mollar E, Grecchi B, et al. Comparison of
intermittent positive pressure breathing and tem-
porary positive expiratory pressure in patients with
severe chronic obstructive pulmonary disease. Arch
Bronconeumol 2014;50:18-24.
Mohamed Sh. Mosa, Azza A. El Aziz, Amany R. Mohamed, Marwa M. Shaban. RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE
END EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Int J Physiother Res 2017;5(5):2344-48. ISSN 2321-1822 2348
[10]. NicoliniA, MerliakF, Barlascini C. Use of positive
expiratory pressure during six minute walk test:
results in patients with moderate to severe chronic
obstructive pulmonary disease. Multidiscipl Resp
Med. 2013;8:19.
[11]. Wibmer T, Ridiger S, Heitner C, Kropf-Sanchen C,
Blanta I, Stoiber KM, et al. Effects of nasal positive
expiratory pressure on dynamic hyperinflation and
6- minute walk test in patients with COPD. Respir
Care. 2014;59:699–708.
[12]. Mascardi V, Grecchi B, Barlascini C, Banfi P, Nicolini
A. Effectiveness of temporary positive expiratory
pressure (T-PEP) at home and at hospital in patients
with severe chronic obstructive pulmonary disease.
J Thorac Dis 2016;8(10):2895-2902.
[13]. Su, C-L., Chiang, L. L., Chiang, T. Y., Yu, C. T., Kuo, H. P.,
& Lin, H. C. Domiciliary positive expiratory pres-
sure improves pulmonary function and exercise
capacity pulmonary with chronic obstructive pul-
monary disease. Journal of the Formosan Medical
Association = Taiwan yi zhi, 2007;106(3):204-211.
[14]. Russo D, Simonelli C, Paneroni M, Saleri M, Piroddi
IMG, Cardinale F, et al. ¿Cuál es el nivel óptimo de
presión espiratoria positiva (PEP) capaz de mejorar
la tolerancia a la deambulación de los pacientes
con EPOC grave? Arch Bronconeumol. 2016;52:354–
360.
[15]. Martin AD, Davenport PW. Extrinsic threshold PEEP
reduces post-exercise dyspnea in COPD patients: a
placebo-controlled double-blind cross-over study.
Cardiopulm Phys Ther J. 2011;22:5–10.
How to cite this article:
Mohamed Sh. Mosa, Azza A. El Aziz, Amany R. Mohamed, Marwa M. Shaban.
RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE END
EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Int J Physiother Res 2017;5(5):2344-2348. DOI: 10.16965/ijpr.2017.207
Mohamed Sh. Mosa, Azza A. El Aziz, Amany R. Mohamed, Marwa M. Shaban. RESPONSE OF EXPIRATORY MUSCLES TRAINING TO POSITIVE
END EXPIRATORY PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background: Temporary positive airway pressure (T-PEP) is a tool recently introduced in the treatment of chronic obstructive pulmonary disease (COPD) or bronchiectasis. It demonstrated encouraging results also in severe COPD patients. The aim of this study is verify if adding T-PEP to best bronchodilator therapy both in clinic and home administering could reduce disease exacerbations and improve lung function in patients with severe COPD. Methods: A total of 142 patients with severe COPD (FEV1 <50%) were enrolled; 120 were randomized in three groups: a group treated with T-PEP at home, a group with T-PEP at hospital and a group with medical therapy only (control group). Number of acute exacerbations COPD (AECOPD) after 1 month and 3 months were the primary outcomes. Secondary outcomes were changes in respiratory function parameters (FVC, FEV1, TLC, RV), arterial blood gases, dyspnea and health status assessment scales (Modified Medical Research Council (MMRC), Breathlessness, Cough and Sputum scale (BCSS) and COPD Assessment Test (CAT). The time of daily use of the T-PEP was registered as well as its acceptance using a Likert scale. Results: Ninety-nine patients completed the study. Both the groups who used T-PEP showed a statistical lower number of AECOPD after 1 month and 3 months (P<0.01). Some respiratory functional parameters improved in the two groups treated with T-PEP (FVC, FEV1, RV) (P<0.02) and dyspnea and health status assessment scales (MMRC, BCSS, CAT) (P<0.04; P<0.01; P<0.009). The time of daily using was similar in the two T-PEP groups. Patients treated at home showed a greater acceptance than those treated at hospital (Likert scale 4.7 vs. 5.9) (P<0.01). Conclusions: Patients treated with T-PEP showed a lower number of AECOPD. T-PEP improves functional respiratory parameters and improves dyspnea and health status assessment scales. No adherence difference in hospital and home treatment was found. Patients preferred home treatment.
Article
Full-text available
Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality with increasing rates during the last decades. Due to the progressive nature of the disease, underestimation of symptoms by the patients, lack of knowledge and underuse of spirometry by the Primary Care providers the disease remains under-diagnosed in about half of the cases. Patients with a smoking history of ≥20 pack-years and relevant symptoms (e.g. dyspnea, chronic cough and sputum production) are considered a high risk group. Measurement of spirometric parameters after administration of a short acting bronchodilator confirms the presence of irreversible airflow obstruction and establishes the diagnosis. However in the primary care spirometry is usually not available and differential diagnosis with other obstructive pulmonary diseases (e.g. asthma, bronchiectasis) is not always easy. General Practitioners (GPs) need simple screening tools to decide if a patient belong to a high risk group and pulmonary consultation is necessary. Early and accurate diagnosis of COPD in the primary care setting allowing for a timely and effective management which reduces the rate of decline in lung function improves survival of patients, their quality of life and reduces health-care utilization. The aim of the present review is to provide the existing information about COPD diagnosis and the related problems in the Primary Care. Also we reviewed numerous simple COPD diagnosis questionnaires as well as the use of hand-held flow meters which could be used as effective screening tools.
Article
Full-text available
Background The six-minute walk test (6MWT) is widely used because it is both simple and reliable as a measure of exercise capacity. Individuals with chronic obstructive pulmonary disease (COPD) usually show a limited capacity to perform exercise. Methods Our study is a prospective, randomized controlled trial which uses the 6MWT in one hundred consecutive in and out- patients with moderate to severe COPD to assess the benefit of a simple positive expiratory pressure (PEP) device. PEP device consisted of a PEP valve 5 cmH2O connected to 1-meter tube and a mouthpiece. All the enrolled patients performed a 6MWT before randomization. The following day PEP group patients performed the 6MWT using PEP device. Control group patients performed the 6MWT without this device. The primary outcome was the difference in distance (meters) walked. Results Functional capacity assessed by the distance covered during 6MWT improved in the PEP group more than in the control group. The difference was statistically significant (p < 0.001).Oxygen saturation improved to a statistically significant level during 6MWT (p < 0.01). Heart rate was also reduced (p < 0.03). Conclusions There are few studies demonstrating that PEP devices enhance exercise capacity in COPD patients. Our results has been obtained using only a low positive expiratory pressure (5 cmH2O). In our opinion the strength of this study is the simplicity and the lower cost when compared to other devices and approaches. The study was registered as Chi CTR-ORC-12002173 at http://www.chictr.org.
Article
Full-text available
Purpose: Most patients with chronic obstructive pulmonary disease (COPD) complain of dyspnea during and following exercise, and the development of intrinsic positive end-expiratory pressure (PEEP) is thought to contribute to lung hyperinflation and dyspnea. Many people with COPD use pursed lip breathing (PLB) in an attempt to produce extrinsic PEEP to reduce lung hyperinflation and dyspnea during and following exertion. We hypothesized that the use of a threshold, extrinsic PEEP device would reduce post-exercise dyspnea in people with COPD. Methods: A double blind, crossover study was conducted on post-exercise dyspnea in 8 patients with COPD whose exercise tolerance was limited by dyspnea. Subjects performed two identical 6-minute treadmill bouts that led to a Borg dyspnea rating of at least 5/10. Dyspnea, heart rate, and oxygen-hemoglobin saturation (SpO(2)) were recorded at rest, every 2 minutes during exercise and at 2, 5, and 10 minutes post-exercise. Immediately following the exercise bouts, the subjects used either a threshold PEEP device for 6 breaths at 10 cm H(2)O or a Sham device. Results: Heart rate and SpO(2) were not different between treatments any time point before, during, or after exercise. Dyspnea ratings were not different between devices at rest or during exercise, but were lower in the post-exercise period following use of PEEP (p < 0.05). When asked which device, if any, the subjects would prefer to use to relieve post-exercise dyspnea, 7 of 8 chose the PEEP device and one had no preference. Conclusions: We found that the use of a PEEP device can help reduce postexercise dyspnea in patients with COPD.
Article
Full-text available
Exercise Capacity is the expression of the cardiovascular and of metabolic organic efficiency and represents a important prognostic marker. The Six Minute Walking Test is adopted in the practice for exercise capacity evaluation in the normal subject as in pneumologic or cardiac rehabilitation programs, and in both pediatric and elderly ages. The aim of the work is to present a practical summary of the application of the six minutes walking test, according to the American Thoracic Society statement. We reviewed the various experiences of its application, and reported the indications, clinical interpretation parameters, relationship and correlation between functional and clinical parameters (hospitalization, quality of life, therapy and exercise control response and compliance), the basic and advanced protocol, the application modality, the reporting models, and the educational checklist.
Article
Full-text available
Maximal inspiratory pressure (MIP) was assessed in 4,443 ambulatory participants of the Cardiovascular Health Study, 65 yr of age and older, sampled from four communities. Maximal expiratory pressure (MEP) was also measured in 790 participants from a single clinic. Positive predictors of MIP included male sex, FVC, handgrip strength, and higher levels of lean body mass (or low bioelectric resistance). Negative predictors were age, current smoking, self-reported fair to poor general health, and waist size. Both participant and technician learning effects were noted, but there was no independent effect of race, hypertension, cardiovascular disease, or diabetes. A healthy subgroup was identified by excluding current smokers, those with fair to poor general health, or an FEV1 less than 65% of predicted. Mean values determined from the healthy group were 57/116 cm H2O (MIP/MEP) for women, and 83/174 for men. Lower limits of the normal range (fifth percentiles) were 45 to 60% of the mean predicted values. The reference equations derived from this group of healthy 65 to 85-yr-olds may be used by pulmonary function laboratories and respiratory therapists who evaluate the respiratory muscle strength of elderly patients.
Article
Resumen Introducción La aplicación de dispositivos de presión espiratoria positiva (PEP) durante el ejercicio se había propuesto con el objetivo de contrarrestar la hiperinflación pulmonar, reducir la disnea y mejorar así la tolerancia al ejercicio de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) grave. En este ensayo controlado, aleatorizado y cruzado se investigó el efecto de dos niveles de PEP (1 cm de H2O y 10 cm de H2O) sobre la distancia recorrida por pacientes con EPOC grave durante la prueba de marcha de 6 min (PM6 M). Los criterios de valoración secundarios fueron los efectos de la PEP sobre variables fisiológicas y de la función pulmonar. Métodos Se reclutaron setenta y dos pacientes con EPOC grave, hospitalizados o ambulatorios, derivados a nuestros hospitales. El primer día de este estudio aleatorizado y cruzado se efectuó la PM6 M sin ningún dispositivo, y posteriormente se repitió con una PEP de 1 cm de H2O (PEP1) y de 10 cm de H2O (PEP10). Antes y después de cada PM6 M se practicaron espirometrías lentas y forzadas, que incluyeron la medición de la capacidad inspiratoria. Resultados Cincuenta pacientes (edad media 69,92 años, FEV1 medio 41,42% del previsto) finalizaron el ensayo. La PM6 M mejoró significativamente con los dos niveles de PEP, en comparación con la situación inicial (323,8 m al inicio vs. 337,8 con la PEP1 y 341,8 con la PEP10; p < 0,002 y p < 0,018, respectivamente). La diferencia entre la PEP10 y la PEP1 no fue significativa. No se observaron mejorías en la función pulmonar, los síntomas ni las variables fisiológicas posteriores a la prueba PM6 M. Conclusiones En pacientes con EPOC grave, la aplicación de una PEP de 1 cm de H2O parece mejorar la tolerancia al ejercicio, al igual que lo hace la aplicación de 10 cm H2O y con un grado similar de disnea. Deben realizarse otros estudios para investigar los efectos de los niveles bajos de PEP en los programas de entrenamiento aeróbico.
Article
Results supporting the use and the effectiveness of positive expiratory, pressure devices in chronic obstructive pulmonary disease (COPD) patients are still controversial, We have tested the hypothesis that adding TPEP or IPPB to standard pharmacological therapy may provide additional clinical benefit over, pharmacological therapy only in patients with severe COPD. Fourty-five patients were randomized in three groups: a group was treated; with IPPB,a group was treated with TPEP and a group with pharmacological; therapy alone (control group). Primary outcome measures included the measurement of scale or, questionnaire concerning dyspnea (MRC scale),dyspnea,cough, and, sputum (BCSS) and quality of life (COPD assessment test) (CAT). Secondary, outcome measures were respiratory function testing,arterial blood gas,analysis,and hematological examinations. Both patients in the IPPB group and in the TPEP group showed a significant, improvement in two of three tests (MRC,CAT) compared to the control, group.However,in the group comparison analysis for, the same variables between IPPB group and TPEP group we observed a, significant improvement in the IPPB group (P≤.05 for MRC and P≤.01 for, CAT). The difference of action of the two techniques are evident in the results of, pulmonary function testing: IPPB increases FVC, FEV1, and MIP; this reflects, its capacity to increase lung volume. Also TPEP increases FVC and FEV1 (less, than IPPB), but increases MEP, while decreasing total lung capacity and, residual volume. The two techniques (IPPB and TPEP) improves significantly dyspnea; quality of; life tools and lung function in patients with severe COPD. IPPB demonstrated a greater effectiveness to improve dyspnea and quality of life tools (MRC, CAT) than TPEP.